
THC
21.2–24.8%
CBD
0.4%
Cherry Cough is a hybrid listed for nausea and pain relief, testing between 22% and 24% THC.
No effect, terpene or flavor data specific to Cherry Cough has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
Explore More
THC in this profile
24.8% THC
About Cherry Cough
Cherry Cough is a hybrid documented for two specific medical applications, nausea and pain, alongside a strong THC range of 22% to 24%. The breeder is listed only as Unknown Breeder, meaning no specific seed bank or cultivator is credited with this particular cut, and no parent lineage, flowering time, height, yield, or terpene data accompanies the listing. Despite the missing pedigree, the medical use list and the THC figures are both clearly documented, giving patients tracking nausea or pain relief a specific data point to reference even without knowing the strain's full breeding history. A roughly three-point spread in the THC range suggests normal batch variation rather than a single fixed potency. At 22-24% THC alongside its listed medical applications, Cherry Cough combines a genuinely strong number with a use case that's more specifically documented than most strains carry.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Cherry Cough
Is Cherry Cough an Indica, Sativa, or Hybrid?
Cherry Cough is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Cherry Cough?
Cherry Cough: 24.8% THC and 0.4% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.